We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.12B
AUM Growth
-$199M
Cap. Flow
-$200M
Cap. Flow %
-3.9%
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94

Top Sells

Rank Stock Value
1
BEAV
B/E Aerospace Inc
BEAV
+$48.6M
2
VTR icon
Ventas
VTR
+$42.2M
3
CNC icon
Centene
CNC
+$38.9M
4
MANH icon
Manhattan Associates
MANH
+$30.4M
5
CRM icon
Salesforce
CRM
+$24.4M

Sector Composition

Rank Sector Weight
1 Healthcare 16.09%
2 Financials 14.79%
3 Technology 14.28%
4 Consumer Discretionary 14.11%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
251
Eli Lilly
LLY
$1.05T
$1.5M 0.03%
20,396
-770
-4% -$57.3K
TM icon
252
Toyota
TM
$227B
$1.5M 0.03%
12,791
-1,112
-8% -$130K
CEB
253
DELISTED
CEB Inc.
CEB
$1.48M 0.03%
24,424
+135
+0.6% +$7.45K
FMX icon
254
Fomento Económico Mexicano
FMX
$41B
$1.45M 0.03%
18,962
-981
-5% -$84K
CERN
255
DELISTED
Cerner Corp
CERN
$1.44M 0.03%
30,352
-1,705
-5% -$90.5K
NUE icon
256
Nucor
NUE
$57.3B
$1.41M 0.03%
23,755
+15,270
+180% +$854K
ENV
257
DELISTED
ENVESTNET, INC.
ENV
$1.41M 0.03%
40,000
+2,058
+5% +$73.8K
MRCC
258
DELISTED
Monroe Capital Corp
MRCC
$1.39M 0.03%
90,146
+11,427
+15% +$172K
MOS icon
259
The Mosaic Company
MOS
$7.55B
$1.35M 0.03%
46,098
+12,652
+38% +$339K
ROP icon
260
Roper Technologies
ROP
$41.8B
$1.32M 0.03%
7,229
-894
-11% -$160K
TMO icon
261
Thermo Fisher Scientific
TMO
$233B
$1.31M 0.03%
9,291
-1,244
-12% -$183K
VEEV icon
262
Veeva Systems
VEEV
$45.8B
$1.3M 0.03%
32,022
+37
+0.1% +$1.51K
CLB icon
263
Core Laboratories
CLB
$564M
$1.29M 0.03%
10,730
+2,482
+30% +$275K
MAIN icon
264
Main Street Capital
MAIN
$5.48B
$1.29M 0.03%
34,994
+6,095
+21% +$215K
RIO icon
265
Rio Tinto
RIO
$170B
$1.28M 0.03%
33,345
-7,693
-19% -$282K
STJ
266
DELISTED
St Jude Medical
STJ
$1.28M 0.02%
15,936
+96
+0.6% +$7.62K
LDL
267
DELISTED
Lydall, Inc.
LDL
$1.27M 0.02%
20,502
+2,555
+14% +$141K
NJ
268
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$1.26M 0.02%
58,905
-2,110
-3% -$45.2K
VGK icon
269
Vanguard FTSE Europe ETF
VGK
$31B
$1.26M 0.02%
26,246
-32,908
-56% -$1.55M
LKQ icon
270
LKQ Corp
LKQ
$6.42B
$1.25M 0.02%
40,860
-1,600
-4% -$52.2K
ARCC icon
271
Ares Capital
ARCC
$14.3B
$1.24M 0.02%
75,387
+8,802
+13% +$139K
EFOR
272
Everforth Inc
EFOR
$1.3B
$1.24M 0.02%
27,977
+1,360
+5% +$54.1K
VIG icon
273
Vanguard Dividend Appreciation ETF
VIG
$113B
$1.23M 0.02%
14,492
+3,478
+32% +$292K
WM icon
274
Waste Management
WM
$87B
$1.23M 0.02%
17,402
+1,139
+7% +$76.2K
FWRD icon
275
Forward Air
FWRD
$598M
$1.23M 0.02%
25,939
+1,457
+6% +$66.7K

Similar funds

Geneva Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.

  • Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
  • Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
  • Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
  • Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
  • Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
  • Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.

Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.